A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
Clinical trial NCT02025907 · COMPLETED
Trial details
- NCT number
- NCT02025907
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2015-09-01
- Enrollment
- 218
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.